Duke University in North Carolina has been at the centre of some of the most exciting trials relating to the treatment of neurological conditions. Such has been the success of their safety and efficacy clinical trials, they are now able to offer cord blood therapy to...
A ground-breaking trial has been announced in the USA at the Children’s Hospital Los Angeles with the aim of helping babies born with a heart defect. Dr. Ram Kuma Subramanyan, a Cardiothoracic Surgeon at the CHLA explained: “About two or three decades ago, this...
In the USA, the Food & Drug Authority (FDA) has given permission to Duke University Medical Center to offer cord blood therapy to children with neurological conditions including: Autism spectrum disorder Autism Cerebral palsy Hydrocephalus Apraxia of speech...
The American Heart Association has recently published results of a study that saw patients with heart failure receive an intravenous infusion of umbilical cord stem cells. The study comprised of 30 patients aged 18 – 75 who had stable heart failure. Participants were...
In early July 2017 a panel of cancer experts unanimously endorsed CAR-T treatment for leukaemia. With FDA approval expected, it will become the first gene therapy to reach the market creating a ‘living drug’ that genetically alters a patients own cells to fight...
An estimated 1 in 100 children(1) in the UK have some form of autism and currently four times more boys are diagnosed with the condition than girls.(2) Autism is a spectrum disorder meaning that the symptoms are broad and vary greatly in severity. However they include...
Tiny Particles From Umbilical Cord Stem Cells Could Help Regenerate Sun-Damaged Skin, Study Finds
